Clinical Trial Update: Effect of Secukinumab in the Treatment of Psoriatic Arthritis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating secukinumab for psoriatic arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• Secukinumab (secukinumab)

Snippet

Sponsor: University of Liverpool | Conditions: Psoriatic Arthritis | Phase 2 | Status: COMPLETED